Updated September 6th. 2020
Maybe you’ve heard conflicting reports on the safety and effectiveness of CBD, making it difficult for you to decide whether or not this plant compound is worth a try. The CBD industry is still relatively new, so it’s not surprising that a lot of people don’t understand a whole lot about it, or trust it completely. After all, if you’re going to be consuming a natural wellness supplement on an ongoing basis, you want to make sure that it’s safe and effective, right?
A Background of WHO and NIDA
If you’re on the fence about CBD, you should know that major health organizations are hopefully optimistic, like much of the general public. NIDA (National Institute on Drug Abuse) and WHO (World Health Organization) have both thoroughly reviewed all available CBD-focused research and have reported that it’s capable of living up to expectations.
So, who are these organizations, and why do their opinions matter? In this article, take a closer look at WHO and NID to understand why their pro-CBD statements are so crucial to the hemp industry.
NIDA (National Institute on Drug Abuse)
NIDA is an instate funded by the federal government to conduct critical research regarding drugs. Their mission is to put an end to drug abuse and drug addiction throughout the country. They hope to achieve this mission by using scientific studies to help promote new legislation regarding how drugs are produced, marketed, sold, and consumed by the general public.
NIDA’s origins go back to 1935 when its founders created one of the first drug addiction centers in a hospital in Lexington, Kentucky. In 1974, they became an official government organization, receiving funding to do proper and thorough research. Their work is considered prolific, as they’ve developed new ways to research and test drugs to help determine their safety, effectiveness, and potential to be addictive. Recently, NIDA was granted permission to conduct medical marijuana research.
WHO (World Health Organization)
The World Health Organization (WHO) is an agency funded by the United Nations. WHO was established in 1948 and is headquartered in Switzerland. To date, 61 countries around the world have signed the constitution created by the World Health Organization, granting them an incredible authority on an international level.
While NIDA deals specifically with drugs, WHO deals with health matters around the world. They’re widely credited with the sharp decrease in cases of smallpox and also devoted much of their efforts to researching and trying to eradicate tuberculosis, HIV and the Ebola virus. Their mission is simple: to ensure that everyone on the planet has the potential to attain optimal health.
Because CBD exists in the natural health market, the World Health Organization has also studied the hemp plant intensively. Due to their authority on worldwide health matters, their views on CBD are highly respected by lawmakers and legislatures. Due to their uniquely high budget, the World Health Organization has been able to study CBD on a level that other organizations simply cannot due to a lack of funds.
What These Two Organizations Mean to the CBD Industry
WHO and NIDA are crucial to pro-CBD laws throughout the country and to the general public’s trust in the industry. Both organizations have thoroughly researched CBD using their enormous budgets, and both have reported positive findings.
In 2015, NIDA published a report advocating for CBD. NIDA also stressed the importance of as much CBD-focused research as possible to make hemp-based products more accessible to the general public. NIDA also emphasized that, according to research, CBD appears to be safe, with no risk of significant side effects or risk of addiction.
WHO has also been outspoken on the CBD industry, stating that it’s generally well tolerated with a good safety profile. WHO has additionally indicated that CBD should be considered medicine and supported by the medical industry due to its many potential effects and high safety profile.
Industry Support Seems to Be Growing
If it weren’t for organizations like WHO and NIDA supporting CBD, the industry could very well be struggling to find fair legislation. It’s essential to keep in mind that both of these significant organizations developed their pro-CBD stance after reviewing extensive research findings. Therefore, take into consideration that these prestigious organizations advocate for hemp.
Joshua Willard (Freelance CBD Content Writer/Editor)
*These statements have not been evaluated by the food and drug administration (FDA). These products are not intended to diagnose, treat, cure, or prevent any disease